SA

Sultana Asma

Active Director Director DIN 07965088
DIN 07965088 First appointment Oct 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2017
Shareholding value •••• Premium profile

About Sultana Asma

Data last updated:

Sultana Asma is a Director at Seaford Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Seaford Pharmaceuticals Private Limited reported revenue of ₹5.3 Lakh (FY 2024).

DIN 07965088
Primary Designation Director
Industry Pharma
First Appointment 23 Oct 2017
Oldest Company Age 9 yrs
Largest company Seaford Pharmaceuticals Private Limited · ₹5.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Oct 20172017₹5.3 Lakh (FY 2024)Active

Board colleagues of Sultana Asma

Directorship timeline

Open interactive timeline →
Seaford Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sultana Asma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sultana Asma

Sultana Asma currently holds 1 directorship: Seaford Pharmaceuticals Private Limited (Director, since 23 Oct 2017, revenue ₹5.3 Lakh (FY 2024)).

Sultana Asma was first appointed on 23 Oct 2017 as Director at Seaford Pharmaceuticals Private Limited.

The current boards of Sultana Asma's companies include Syed Mohammed Abubakar Suffyan (Seaford Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available